Screening for diabetes in optometry practices: Acceptability to users

Ophthalmic and Physiological Optics

Volumn 31, Issue 4, 2011, Pages 367-374

  Howse, Jennifer H ^a   Jones, Steve ^b   Hungin, A Pali S ^a  

^a DURHAM UNIVERSITY   (United Kingdom)

^b JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Pre diabetes optometry practice; Random capillary blood glucose test; Screening; Type 2 diabetes

Indexed keywords

ARTICLE; BLOOD; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; OPTOMETRY; PATIENT ATTITUDE; PATIENT SELECTION; QUESTIONNAIRE; RISK FACTOR; STATISTICS;

BLOOD GLUCOSE; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OPTOMETRY; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SELECTION; QUESTIONNAIRES; RISK FACTORS;

EID: 79958859533     PISSN: 02755408     EISSN: 14751313     Source Type: Journal    
DOI: 10.1111/j.1475-1313.2011.00826.x     Document Type: Article

References (35)

1. Wild S, Roglic G, Green A, Sicree R & King H. Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
2. Thomas C, Hypponen E & Power C. Diabetes risk in British adults in mid life: a national prevalence study of glycated haemoglobin. Diabet Med 2007; 24: 317-321.
3. Dunstan DW, Zimmet PZ, Welborn TA et al. The rising prevalence of diabetes and impaired glucose tolerance - The Australian diabetes, obesity and lifestyle study. Diabetes Care 2002; 25: 829-834.
4. Pierce MB, Zaninotto P, Steel N & Mindell J. Undiagnosed diabetes-data from the English longitudinal study of ageing. Diabet Med 2009; 26: 679-685.
5. Goyder E, Wild S, Fischbacher C, Carlisle J & Peters J. Evaluating the impact of a national pilot screening programme for type 2 diabetes in deprived areas of England. Fam Pract 2008; 25: 370-375.
6. Barnard NAS, Allen RJ & Field AF. Referrals for vasular hypertension in a group of 45-64-year-old paients. Ophthalmic Physiol Opt 1991; 11: 201-205.
7. Hurcomb PG & Wolffsohn JS. The management of systemic hypertension in optometric practice. Ophthalmic Physiol Opt 2005; 25: 523-533.
8. Schwartz SH. The optometrist's role in the management of clinical depressive disorders. Optometry 2007; 78: 469-473.
9. Thompson C, Harrison RA, Wilkinson SC, Scott-Samuel A, Hemmerdinger G & Kelly SP. Attitudes of community optometrists to smoking cessation: an untapped opportunity overlooked. Ophthalmic Physiol Opt 2007; 27: 389-393.
10. North RV. Early ocular and non-ocular indications of diabetes mellitus. Ophthalmic Physiol Opt 1998; 18: 167-172.
11. Warburton TJ, Hale PJ & Dewhurst JA. Evaluation of a local optometric diabetic retinopathy screening service. Diabet Med 2004; 21: 632-635.
12. Schmid KL, Swann PG, Pedersen C & Scmid LM. The detection of diabetic retinopathy by Australian optometrists. Clin Exp Optom 2002; 85: 211-288.
13. McCarty CA, McKay R & Keeffe JE. Management of diabetic retinopathy by Australian optometrists. Aust N Z J Ophthalmol 1999; 27: 404-409.
14. Feitosa-Santana C, Paramei GV, Nishi M, Gualtieri M, Costa MF & Ventura DF. Color vision impairment in type 2 diabetes assessed by the D-15d test and the Cambridge colour test. Ophthalmic Physiol Opt 2010; 30: 717-723.
15. Pritchard N, Edwards K, Vagenas D et al. Corneal sensitivity as an ophthalmic marker of diabetic neuropathy. Optom Vis Sci 2010; 87: 1003-1008.
16. Eva PR, Pascoe PT & Vaughan DG. Refractice change in hyperglycemia - hyperopia, not myopia. Br J Ophthalmol 1982; 66: 500-505.
17. Harrison RJ, Wild JM & Hobley AJ. Referral patterns to an ophthalmic outpatient clinic by general practitioners and ophthalmic opticians and the role of these professionals in screening for ocular disease. Br Med J 1988; 297: 1162-1167.
18. Elliott DB. Introduction to the promary eye care examination. In: Clinical Procedures in Primary Eye Care (Elliott DB, editor), 3rd edition, Butterworth Heinemann: Edinburgh, 2007; pp. 11-28.
19. Howse JH, Jones S & Hungin APS. Screening and diagnosing diabetes in optometrists' practices an evaluation of perceptions, attitudes and beliefs. Practical Diabetes int 2010; 27: 55-58.
20. Engelgau MM, Thompson TJ, Smith PJ et al. Screening for diabetes mellitus in adults. The utility of random capillary blood glucose measurements. Diabetes Care 1995; 18: 463-466.
21. Eborall H, Davies R, Kinmouth A-L, Griffin S & Lawton J. Patients' experience of sceening for type 2 diabetes: prospective qualititative study embedded in the ADDITION (Cambridge) randomised controlled trial. Br Med J 2007; 335: 490-493.
22. Moses RG, Colagiuri S & Shannon AG. Effectiveness of mass screening for diabetes mellitus using random capillary blood glucose measurements. Med J Aust 1985; 143: 544-546.
23. George PM, Valabhji J, Dawood M & Henry JA. Screening for Type 2 diabetes in the accident and emergency department. Diabet Med 2005; 22: 1766-1769.
24. Andersson DKG, Lundblad E & Svardsudd K. A model for early diagnosis of type 2 diabetes mellitus in primary health care. Diabet Med 1993; 10: 167-173.
25. Mann E, Prevost AT, Griffin S et al. Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): trial protocol. BMC Public Health 2009; 9: 63.
26. Early identification of diabetes for community pharmacists: Diabetes UK & Royal Pharmaceutical Society of Great Britain 2006 11 Sept 2006.
27. Lawal AG, Patel MG, Wong ICK & Chrystyn H. Opportunistic screening for type 2 diabetes within inner city community pharmacies. Int J Pharm Pract 2003; 11: R10.
28. Diabetes UK. Our 2minute test., accessed 12/11/08.
29. Zhang P, Cadwell B, Engelgau MM, Benjamin SM, Valdez R & Narayan KMV. Efficient cutoff points for three screening tests for detecting undiagnosed diabetes and pre-diabetes - An economic analysis. Diabetes Care 2005; 28: 1321-1325.
30. Howse JH, Jones S & Hungin APS. Unconventional settings for screening and identifying diabetes: an example from optometric practice. Br J Gen Pract 2011; 63: in press.
31. Krass I, Mitchell B, Clarke P et al. Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. Diabetes Res Clin Pract 2007; 75: 339-347.
32. Dalsgaard EM, Lauritzen T, Christiansen T, Mai KS, Borch-Johnsen K & Sandbaek A. Socioeconomic factors related to attendance at a Type 2 diabetes screening programme. Diabet Med 2009; 26: 518-525.
33. Howse JH. Screening for diabetes in optometric practice, Doctoral thesis, Durham University; 2010.
34. Sargeant LA, Kinmonth A, Wareham NJ & Griffin SJ. Feasibility and uptake of screening for type 2 diabetes in primary care. Diabetologia 2006; 49: 0324.
35. Van den Donk M, Sandbaek A, Borch-Johnsen K et al. Population-based screening for type 2 diabetes in Denmark, the Netherlands and the United Kingdom: uptake and prevalence in the ADDITION study. Diabetologia 2009; 52: 840.